Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: J Hepatol. 2015 Mar 28;63(2):429–436. doi: 10.1016/j.jhep.2015.03.023

Fig. 2. Decrease in the number of tumor nodules following deletion of FoxM1.

Fig. 2

Transgenic male mice (Alb-H-ras12V FoxM1+/+ MxCre and Alb-H-ras12V FoxM1fl/fl MxCre) at 8 months of age were injected with 5 dosages of polyIpolyC (panels A and B) or 10 dosages (panel C) of polyIpolyC. The numbers of the tumor nodules were compared 4 weeks after the last injection. Box plots for the numbers are shown along with p values.